REFRACTIVE SURGERY MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Refractive Surgery Market, By Technology (Laser Systems and Diagnostic Equipments), By Application (Myopia, Hyperopia, Astigmatism, Presbyopia, and Dry eyes), By Type of Procedure (Laser-Assisted in Situ Keratomileusis (LASIK), Photorefractive Keratectomy (PRK), Radial keratotomy (RK), Astigmatic keratotomy (AK), Automated lamellar keratoplasty (ALK), Laser thermal keratoplasty (LTK), and Others), By End User (Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

In June 2024, Alcon, an ophthalmology company, and the World Council of Optometry (WCO) renewed their collaboration to update the Dry Eye Wheel, an educational tool for optometrists. This resource aims to improve the diagnosis and management of dry eye disease (DED) and is accessible through a dedicated website featuring a series of educational webinars.
In May 2024, the Controversies in Modern Eye Care (CIME) conference highlighted significant progress in refractive surgery, intraocular lens (IOL) technology, and genetic research. Experts shared insights into cutting-edge innovations and techniques aimed at enhancing patient outcomes and treatment methodologies.
In January 2024, Bausch + Lomb, an eye health products company, received the U.S. Food and Drug Administration (FDA) approval for the TENEO Excimer Laser Platform, designed for LASIK vision correction surgery targeting myopia and myopic astigmatism. This platform offers enhanced precision and efficiency, potentially improving visual outcomes for patients.
In July 2022, SCHWIND, an eye-tech solutions company, launched an innovative research initiative focused on developing a groundbreaking procedure for correcting refractive errors in corneal surgery. With a total investment exceeding USD 1.73 million, approximately 52% of the funding is provided by the Federal Ministry of Education and Research (BMBF).